ALLISON INQUIRY

Rule 25 Exhibits

Inquiry Rule 25 permits the Chairperson and Inquiry Counsel to jointly agree to admit materials to the Inquiry Record.

This page provides access to materials entered into the record under Rule 25. The exhibit descriptions and available PDF downloads appear below.

R25-A: Application to admit evidence concerning the Drug Test used for the Covid-19 vaccines.
R25-B: List of Adverse Events of Special Interest Received by Pfizer to February 28, 2021 (76 days after Canada began using the Pfizer vaccine).

R25-A: Application to admit evidence concerning the Drug Test used for the Covid-19 vaccines.

R25-A Rule 25 Application to admit evidence concerning the Drug Test used for the Covid-19 vaccines.

DOWNLOAD PDF

Rule 25-1: Food and Drug Regulations, C.R.C, c. 870 section C.08.002

R25-1 Food and Drug Regulations, C.R.C, c. 870 section C.08.002 as it read in 2020 and up to March 18, 2021 (Pre-Covid Drug Approval Test).

DOWNLOAD PDF

Rule 25-2: Interim Order exempting Covid-19 vaccines from the regular drug approval process

R25-2 Interim Order exempting Covid-19 vaccines from the regular drug approval process and creating a substitute process for their approval. This Interim Order was made on September 16, 2020 pursuant to section 30.1 of the Food and Drugs Act, R.S.C., 1985, c. F-27 (Interim Order).

DOWNLOAD PDF

Rule 25-3: Order in Council extending the exemption of Covid-19 vaccines from the regular drug approval process

R25-3 Order in Council dated October 3, 2020, extending the exemption of Covid-19 vaccines from the regular drug approval process, and continuing the substitute process for their approval. Canada Gazette, Part I, Volume 154, Number 40: Orders in Council.

DOWNLOAD PDF

Rule 25-4: Regulation SOR/2021-45 incorporating the provisions of the Interim Order into the Food and Drug Regulations

R25-4 Regulation SOR/2021-45 which on March 18, 2021, incorporated the provisions of the Interim Order, with some minor changes, into the Food and Drug Regulations, C.R.C., c. 870.

DOWNLOAD PDF

Rule 25-5: Regulation SOR/2024-238 sections 24-40 amending the Food and Drug Regulations

R25-5 Regulation SOR/2024-238 sections 24-40, which on November 29, 2024, amended the Food and Drug Regulations. The main change was to replace the term designated COVID-19 drug with the term public health emergency drug.

DOWNLOAD PDF

Rule 25-6: List of Conditions for public health emergency drugs

R25-6 List of Conditions for public health emergency drugs. The only condition on the list is Covid-19. This enables Covid-19 vaccines to remain exempt from proving safety and efficacy when seeking approval for use.

DOWNLOAD PDF